Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

H.R. 3066 · 118th Congress · Health

PREPARE Act

Died in committee4k words Introduced May 2, 2023 · Latest action May 5, 2023

FollowRead the text
How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedMay 2, 2023 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill establishes the National Commission on the COVID-19 Pandemic in the legislative branch and sets out its duties and membership.

The commission must investigate and report on the nation's preparedness for and response to the COVID-19 pandemic. It terminates 60 days after the submission of its final report.

The bill exempts the commission from certain requirements that apply to federal advisory committees.

Congressional Research Service · summary of “Introduced in House” version · May 2, 2023

Who lobbies on it

2 organizations · 6 filings · Q2 2023–Q4 2024

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. The Vanguard Group, Inc. 4 of 7 quarters
    “Mutual fund, ETF, money market mutual fund, securities, and systemic risk issues; equity market structure. HR 4645, Empowering Shareholders Act of 2023; HR 4767, Protecting American's Retirement Savings from Politics Act. SEC proposal on liquidity risk management and swing pricing. H.R. 3066, Retirement Fairness for…”

    Q4 2024 filing · $2.3M lobbying spend in 2024, all issues

  2. Biotechnology Innovation Organization 2 of 7 quarters
    “340B Drug Discount Program ---H.R.3290: 340B Drug Discount Program ---Program Implementation & Oversight ---340B Accountability Act ---General ---H.R.2534: PROTECT 340B Act of 2023 ---RFI Accelerated Approval --- H.R.2408: Access to Innovative Treatments Act of 2023 Alternative Funding Programs ---General Biodefense…”

    Q3 2023 filing · $9.0M lobbying spend in 2023, all issues

Organizations that named H.R. 3066 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

4 actions · newest first
  1. May 5, 2023Referred to the Subcommittee on Health.
  2. May 3, 2023Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.
  3. May 2, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committees on Financial Services, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. May 2, 2023Introduced in House